BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 30267477)

  • 1. Proteomic Profiling of Iron-Treated Ovarian Cells Identifies AKT Activation that Modulates the CLEAR Network.
    Rockfield S; Guergues J; Rehman N; Smith A; Bauckman KA; Stevens SM; Nanjundan M
    Proteomics; 2018 Dec; 18(23):e1800244. PubMed ID: 30267477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Iron modulates cell survival in a Ras- and MAPK-dependent manner in ovarian cells.
    Bauckman KA; Haller E; Flores I; Nanjundan M
    Cell Death Dis; 2013 Apr; 4(4):e592. PubMed ID: 23598404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iron alters cell survival in a mitochondria-dependent pathway in ovarian cancer cells.
    Bauckman K; Haller E; Taran N; Rockfield S; Ruiz-Rivera A; Nanjundan M
    Biochem J; 2015 Mar; 466(2):401-13. PubMed ID: 25697096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AKT inhibition-mediated dephosphorylation of TFE3 promotes overactive autophagy independent of MTORC1 in cadmium-exposed bone mesenchymal stem cells.
    Pi H; Li M; Zou L; Yang M; Deng P; Fan T; Liu M; Tian L; Tu M; Xie J; Chen M; Li H; Xi Y; Zhang L; He M; Lu Y; Chen C; Zhang T; Wang Z; Yu Z; Gao F; Zhou Z
    Autophagy; 2019 Apr; 15(4):565-582. PubMed ID: 30324847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tanshinone I attenuates the malignant biological properties of ovarian cancer by inducing apoptosis and autophagy via the inactivation of PI3K/AKT/mTOR pathway.
    Zhou J; Jiang YY; Chen H; Wu YC; Zhang L
    Cell Prolif; 2020 Feb; 53(2):e12739. PubMed ID: 31820522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sanguinarine inhibits epithelial ovarian cancer development via regulating long non-coding RNA CASC2-EIF4A3 axis and/or inhibiting NF-κB signaling or PI3K/AKT/mTOR pathway.
    Zhang S; Leng T; Zhang Q; Zhao Q; Nie X; Yang L
    Biomed Pharmacother; 2018 Jun; 102():302-308. PubMed ID: 29571014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of PI3K/AKT/mTOR and MAPK signaling pathways decreases progranulin expression in ovarian clear cell carcinoma (OCCC) cell line: a potential biomarker for therapy response to signaling pathway inhibitors.
    Perez-Juarez CE; Arechavaleta-Velasco F; Zeferino-Toquero M; Alvarez-Arellano L; Estrada-Moscoso I; Diaz-Cueto L
    Med Oncol; 2019 Nov; 37(1):4. PubMed ID: 31713081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of YAP1 as a Marker of Sensitivity to Dual AKT and P70S6K Inhibition in Ovarian and Uterine Malignancies.
    Previs RA; Armaiz-Pena GN; Ivan C; Dalton HJ; Rupaimoole R; Hansen JM; Lyons Y; Huang J; Haemmerle M; Wagner MJ; Gharpure KM; Nagaraja AS; Filant J; McGuire MH; Noh K; Dorniak PL; Linesch SL; Mangala LS; Pradeep S; Wu SY; Sood AK
    J Natl Cancer Inst; 2017 Jul; 109(7):. PubMed ID: 28376174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Grifolin induces autophagic cell death by inhibiting the Akt/mTOR/S6K pathway in human ovarian cancer cells.
    Che X; Yan H; Sun H; Dongol S; Wang Y; Lv Q; Jiang J
    Oncol Rep; 2016 Aug; 36(2):1041-7. PubMed ID: 27277722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knockdown of Hypoxia-Inducible Factor 1α (HIF-1α) Promotes Autophagy and Inhibits Phosphatidylinositol 3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Signaling Pathway in Ovarian Cancer Cells.
    Huang J; Gao L; Li B; Liu C; Hong S; Min J; Hong L
    Med Sci Monit; 2019 Jun; 25():4250-4263. PubMed ID: 31175269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Daphnetin triggers ROS-induced cell death and induces cytoprotective autophagy by modulating the AMPK/Akt/mTOR pathway in ovarian cancer.
    Fan X; Xie M; Zhao F; Li J; Fan C; Zheng H; Wei Z; Ci X; Zhang S
    Phytomedicine; 2021 Feb; 82():153465. PubMed ID: 33486268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Icariin enhances the chemosensitivity of cisplatin‑resistant ovarian cancer cells by suppressing autophagy via activation of the AKT/mTOR/ATG5 pathway.
    Jiang S; Chang H; Deng S; Fan D
    Int J Oncol; 2019 Jun; 54(6):1933-1942. PubMed ID: 31081049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MITF-MIR211 axis is a novel autophagy amplifier system during cellular stress.
    Ozturk DG; Kocak M; Akcay A; Kinoglu K; Kara E; Buyuk Y; Kazan H; Gozuacik D
    Autophagy; 2019 Mar; 15(3):375-390. PubMed ID: 30290719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-203a-3p regulates the biological behaviors of ovarian cancer cells through mediating the Akt/GSK-3β/Snail signaling pathway by targeting ATM.
    Liu HY; Zhang YY; Zhu BL; Feng FZ; Zhang HT; Yan H; Zhou B
    J Ovarian Res; 2019 Jul; 12(1):60. PubMed ID: 31277702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Akt-dependent nuclear localization of Y-box-binding protein 1 in acquisition of malignant characteristics by human ovarian cancer cells.
    Basaki Y; Hosoi F; Oda Y; Fotovati A; Maruyama Y; Oie S; Ono M; Izumi H; Kohno K; Sakai K; Shimoyama T; Nishio K; Kuwano M
    Oncogene; 2007 Apr; 26(19):2736-46. PubMed ID: 17072343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Curcumin-induced apoptosis in ovarian carcinoma cells is p53-independent and involves p38 mitogen-activated protein kinase activation and downregulation of Bcl-2 and survivin expression and Akt signaling.
    Watson JL; Greenshields A; Hill R; Hilchie A; Lee PW; Giacomantonio CA; Hoskin DW
    Mol Carcinog; 2010 Jan; 49(1):13-24. PubMed ID: 19676105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FAM83D inhibits autophagy and promotes proliferation and invasion of ovarian cancer cells via PI3K/AKT/mTOR pathway.
    Zhu H; Diao S; Lim V; Hu L; Hu J
    Acta Biochim Biophys Sin (Shanghai); 2019 May; 51(5):509-516. PubMed ID: 30939187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long noncoding RNA-JPX predicts the poor prognosis of ovarian cancer patients and promotes tumor cell proliferation, invasion and migration by the PI3K/Akt/mTOR signaling pathway.
    Li J; Feng L; Tian C; Tang YL; Tang Y; Hu FQ
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8135-8144. PubMed ID: 30556851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ivermectin Augments the In Vitro and In Vivo Efficacy of Cisplatin in Epithelial Ovarian Cancer by Suppressing Akt/mTOR Signaling.
    Zhang X; Qin T; Zhu Z; Hong F; Xu Y; Zhang X; Xu X; Ma A
    Am J Med Sci; 2020 Feb; 359(2):123-129. PubMed ID: 32039764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen and progestin regulate metastasis through the PI3K/AKT pathway in human ovarian cancer.
    Hua K; Feng W; Cao Q; Zhou X; Lu X; Feng Y
    Int J Oncol; 2008 Nov; 33(5):959-67. PubMed ID: 18949358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.